Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Eur J Cancer

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    May 2017
  1. BRIGHENTI M, Petrelli F, Barni S, Conti B, et al
    Radical treatment of oligometastatic non-small cell lung cancer: Ready for prime time?
    Eur J Cancer. 2017;79:149-151.
    PubMed     Text format     Abstract available


  2. PASTORINO U, Morelli D, Leuzzi G, Gisabella M, et al
    Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer.
    Eur J Cancer. 2017;79:90-97.
    PubMed     Text format     Abstract available


    April 2017
  3. GIROUX LEPRIEUR E, Dumenil C, Julie C, Giraud V, et al
    Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges.
    Eur J Cancer. 2017;78:16-23.
    PubMed     Text format     Abstract available


    February 2017
  4. WALDER D, O'Brien M
    Looking back and to the future: Are we improving 'cure' in non-small cell lung cancer?
    Eur J Cancer. 2017;75:192-194.
    PubMed     Text format     Abstract available


    December 2016
  5. GEERSE OP, Hoekstra-Weebers JE, Stokroos MH, Burgerhof JG, et al
    Structural distress screening and supportive care for patients with lung cancer on systemic therapy: A randomised controlled trial.
    Eur J Cancer. 2016;72:37-45.
    PubMed     Text format     Abstract available


    November 2016
  6. YAP TA, Macklin-Doherty A, Popat S
    Continuing EGFR inhibition beyond progression in advanced non-small cell lung cancer.
    Eur J Cancer. 2016;70:12-21.
    PubMed     Text format     Abstract available


    June 2016
  7. MOLLER H, Riaz SP, Holmberg L, Jakobsen E, et al
    High lung cancer surgical procedure volume is associated with shorter length of stay and lower risks of re-admission and death: National cohort analysis in England.
    Eur J Cancer. 2016;64:32-43.
    PubMed     Text format     Abstract available


    May 2016
  8. COUREAU G, Salmi LR, Etard C, Sancho-Garnier H, et al
    Low-dose computed tomography screening for lung cancer in populations highly exposed to tobacco: A systematic methodological appraisal of published randomised controlled trials.
    Eur J Cancer. 2016 May 15. pii: S0959-8049(16)32064.
    PubMed     Text format     Abstract available


  9. MINCHOM A, Punwani R, Filshie J, Bhosle J, et al
    A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma.
    Eur J Cancer. 2016;61:102-110.
    PubMed     Text format     Abstract available


    April 2016
  10. SHARP A, Bhosle J, Abdelraouf F, Popat S, et al
    Development of molecularly targeted agents and immunotherapies in small cell lung cancer.
    Eur J Cancer. 2016;60:26-39.
    PubMed     Text format     Abstract available


  11. YANG CY, Lin MW, Chang YL, Wu CT, et al
    Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
    Eur J Cancer. 2016;57:91-103.
    PubMed     Text format     Abstract available


    March 2016
  12. WELLER A, O'Brien ME, Ahmed M, Popat S, et al
    Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer.
    Eur J Cancer. 2016;59:65-78.
    PubMed     Text format     Abstract available


  13. STEFFENS M, Paul T, Hichert V, Scholl C, et al
    Dosing to rash?--The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash.
    Eur J Cancer. 2016;55:131-9.
    PubMed     Text format     Abstract available


    February 2016
  14. KARAYAMA M, Inui N, Fujisawa T, Enomoto N, et al
    Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancer.
    Eur J Cancer. 2016;58:30-37.
    PubMed     Text format     Abstract available


  15. VILLARUZ LC, Socinski MA
    Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes.
    Eur J Cancer. 2016;56:162-171.
    PubMed     Text format     Abstract available


    January 2016
  16. TOKITO T, Azuma K, Kawahara A, Ishii H, et al
    Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
    Eur J Cancer. 2016;55:7-14.
    PubMed     Text format     Abstract available


    December 2015
  17. ABDELRAOUF F, Smit E, Hasan B, Menis J, et al
    Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061).
    Eur J Cancer. 2015;54:35-39.
    PubMed     Text format     Abstract available


  18. FOURNEL P, Vergnenegre A, Robinet G, Lena H, et al
    Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC - IFCT 02-01.
    Eur J Cancer. 2015;52:181-187.
    PubMed     Text format     Abstract available


  19. FITENI F, Vernerey D, Bonnetain F, Vaylet F, et al
    Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.
    Eur J Cancer. 2015;52:120-128.
    PubMed     Text format     Abstract available


    November 2015
  20. ROSSI M, Carioli G, Bonifazi M, Zambelli A, et al
    Trastuzumab for HER2+ metastatic breast cancer in clinical practice: Cardiotoxicity and overall survival.
    Eur J Cancer. 2015;52:41-49.
    PubMed     Text format     Abstract available


    July 2015
  21. PREUSSER M, Berghoff AS, Koller R, Zielinski CC, et al
    Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma.
    Eur J Cancer. 2015 Jul 8. pii: S0959-8049(15)00622.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: